Pink Sheet is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

CDER Outreach Coordinator’s First Task Is Safe Use Initiative

This article was originally published in The Pink Sheet Daily

Executive Summary

John Whyte joins FDA from Discovery Channel to be director of professional affairs and stakeholder engagement.

You may also be interested in...



FDA Safety Meetings: Outpatient Drugs, Hypoglycemia Getting Limelight

US agency's events could address a touchy subject: how much responsibility does FDA have for preventing adverse events, and how much falls to physicians?

FDA Safe Use Initiative Targets NSAIDs, Pediatric Dosing, Drug-Impaired Driving

CDER touts its Safe Use Initiative as addressing OTC and Rx mis-use and reducing risks to consumers by partnering with industry stakeholders and health care professionals. CDER Professional Affairs and Stakeholder Engagement Director John Whyte says he wants to “build capacity” behind the program.

FDA Safe Use Initiative Targets NSAIDs, Pediatric Dosing, Drug-Impaired Driving

CDER touts its Safe Use Initiative as addressing OTC and Rx mis-use and reducing risks to consumers by partnering with industry stakeholders and health care professionals. CDER Professional Affairs and Stakeholder Engagement Director John Whyte says he wants to “build capacity” behind the program.

Related Content

Topics

Latest Headlines
See All
UsernamePublicRestriction

Register

PS075125

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel